title: RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma.
authors.forename: Bálint
authors.initials: B
authors.lastname: Nagy
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.forename: Edoardo
authors.initials: E
authors.lastname: Benedetti
authors.forename: Francesco
authors.initials: F
authors.lastname: Caracciolo
authors.forename: Simone
authors.initials: S
authors.lastname: Pacini
authors.forename: Juhani
authors.initials: J
authors.lastname: Vilpo
authors.forename: Anna
authors.initials: A
authors.lastname: Ferrer
authors.forename: Erkki
authors.initials: E
authors.lastname: Elonen
authors.forename: Kaarle
authors.initials: K
authors.lastname: Franssila
authors.forename: Sakari
authors.initials: S
authors.lastname: Knuutila
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001483:Base Sequence; D017931:DNA Primers; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics*; D000069283:Rituximab; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D017931:DNA Primers; D000069283:Rituximab; D019908:Proto-Oncogene Proteins c-raf